Windlas Biotech Ltd.
NSE: WINDLAS | BSE: 543329
₹888.70
₹11.30
(1.29%)
As on 28-Oct-2026IST
Market cap
₹1,837 Cr
Revenue (TTM)
₹942 Cr
P/E Ratio
27.7
P/B Ratio
3.5
Div. Yield
0.7 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹66 Cr
-
ROE
12.5 %
-
ROCE
16.1 %
-
Industry P/E
34.02
-
EV/EBITDA
15.2
-
Debt to Equity
0.1
-
Book Value
₹257.7
-
EPS
₹31.7
-
Face value
5
-
Shares outstanding
20,636,229
10 Years Aggregate
CFO
₹400.93 Cr
EBITDA
₹588.48 Cr
Net Profit
₹382.32 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Windlas Biotech
| 11.8 | -19.4 | 3.6 | -5.6 | 38.9 | 22.3 | -- |
|
BSE Healthcare
| 13.8 | -4.2 | -1.5 | 10.2 | 21.9 | 14.3 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Windlas Biotech
| -23.8 | 118.5 | 71.4 | -9.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Windlas Biotech
|
888.7 | 1,837.0 | 942.1 | 66.4 | 7.9 | 11.9 | 27.7 | 3.5 |
| 6,237.0 | 15,586.8 | 2,432.1 | 169.6 | 8.7 | 20.8 | 91.9 | 17.2 | |
| 648.5 | 6,915.5 | 1,005.2 | 141.7 | 15.1 | 11.8 | 50.8 | 5.6 | |
| 2,362.8 | 17,958.1 | 2,287.3 | 678.1 | 31.4 | 19.7 | 27 | 4.9 | |
| 2,200.6 | 13,442.4 | 1,479.1 | 198.6 | 18.6 | 30.3 | 67.5 | 16.7 | |
| 1,175.4 | 16,318.4 | 3,329.6 | 720.8 | 26.3 | 18.9 | 23.1 | 3.9 | |
| 3,734.4 | 17,040.6 | 2,569.8 | 735.2 | 34.4 | 19.2 | 23.2 | 3.9 | |
| 5,399.0 | 8,957.1 | 1,432.9 | 356.9 | 30.8 | 58.2 | 25.1 | 14.6 | |
| 932.0 | 18,220.4 | 1,682.5 | 273.5 | 21.0 | 11.1 | 61.3 | 6.8 | |
| 1,085.6 | 10,024.2 | 5,004.4 | 635.3 | 14.5 | 19.8 | 16.3 | 3.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Sigachi Industries IPO: Information analysis
6 min read•By Arul Selvan and Udhayaprakash
3 min read•By Udhayaprakash
6 min read•By Arul Selvan
About Windlas Biotech
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing... services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India. Read more
-
Incorporated
2001
-
Chairman
--
-
Managing Director
Hitesh Windlass
-
Headquarters
Dehradun, Uttarakhand
-
Website
Looking for more details about Windlas Biotech Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Windlas Biotech
What is the current share price of Windlas Biotech Ltd Today?
The share price of Windlas Biotech Ltd is ₹888.70 (NSE) and ₹890.20 (BSE) as of 28-Oct-2026 IST. Windlas Biotech Ltd has given a return of 38.92% in the last 3 years.
What is the current PB & PE ratio of Windlas Biotech Ltd?
The P/E ratio of Windlas Biotech Ltd is 27.66 times as on 28-Oct-2026, a 19 discount to its peers’ median range of 34.02 times.
The P/B ratio of Windlas Biotech Ltd is 3.45 times as on 28-Oct-2026, a 21 discount to its peers’ median range of 4.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
23.43 |
2.77 |
2025 |
35.78 |
4.36 |
2024 |
18.31 |
2.39 |
2023 |
11.06 |
1.18 |
2022 |
12.02 |
1.17 |
What is the 52 Week High and Low of Windlas Biotech Ltd?
The 52-week high and low of Windlas Biotech Ltd are Rs 1,181.90 and Rs 697.40 as of 28-Oct-2026.
What is the market cap of Windlas Biotech Ltd?
Windlas Biotech Ltd has a market capitalisation of ₹ 1,837 Cr as on 28-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Windlas Biotech Ltd?
Before investing in Windlas Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.